Raimondo Di Liello

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941].

Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941].

Journal: ESMO open

Published: December 01, 2024

Erratum to "Unleashing precision: A review of targeted approaches in pleural mesothelioma" [Crit. Rev. Oncol./Hematol. 203C (2024) 104481].

Erratum to "Unleashing precision: A review of targeted approaches in pleural mesothelioma" [Crit. Rev. Oncol./Hematol. 203C (2024) 104481].

Journal: Critical reviews in oncology/hematology

Published: September 24, 2024

Case report: Tracing in parallel the salivary and gut microbiota profiles to assist Larotrectinib anticancer treatment for NTRK fusion-positive glioblastoma.

Case report: Tracing in parallel the salivary and gut microbiota profiles to assist Larotrectinib anticancer treatment for NTRK fusion-positive glioblastoma.

Journal: Frontiers in oncology

Published: July 03, 2024

Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study.

Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study.

Journal: Breast (Edinburgh, Scotland)

Published: February 27, 2024

Unleashing precision: A review of targeted approaches in pleural mesothelioma.

Unleashing precision: A review of targeted approaches in pleural mesothelioma.

Journal: Critical reviews in oncology/hematology

Published: February 11, 2024

Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials.

Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials.

Journal: ESMO open

Published: January 03, 2024

Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.

Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.

Journal: Frontiers in immunology

Published: September 05, 2023

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 21, 2023

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study.

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study.

Journal: BMJ oncology

Published: December 05, 2022

The use of ultrasound in the evaluation of postoperative pneumothorax and lung re-expansion in patients after lung resection.

The use of ultrasound in the evaluation of postoperative pneumothorax and lung re-expansion in patients after lung resection.

Journal: Annali italiani di chirurgia

Published: September 02, 2022

Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.

Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 18, 2022

Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020.

Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020.

Journal: ESMO open

Published: June 29, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026